Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)

Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)

BackgroundGlioma is the most aggressive primary malignant tumor of the central nervous system, characterized by high recurrence rates and resistance to chemoradiotherapy, making therapeutic resistance a major challenge in neuro-oncology. Recent research emphasizes the role of the tumor microenvironm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shishi Yu, Jinya Wu, Yuan Jing, Ping Lin, Lang Lang, Yifan Xiong, Wangzhong Chen, Wenhua Liu, Changpeng Sun, Yuntao Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	glioma chemoradiotherapy resistance tumor microenvironment bibliometric analysis immune infiltration androgen receptor
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1539937/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
by: Tian-Hang Yu, et al.
Published: (2025-01-01)

Identification of key genes to predict response to chemoradiotherapy and prognosis in esophageal squamous cell carcinoma
by: Yingying Cui, et al.
Published: (2024-11-01)

Global research landscape and hotspots for ferroptosis in glioma: A comprehensive bibliometric and visual analysis
by: Xinyue Zheng, et al.
Published: (2025-02-01)

DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma
by: Shuangyue Ma, et al.
Published: (2024-12-01)

<i>CLIC4</i> Is a New Biomarker for Glioma Prognosis
by: Zhichun Liu, et al.
Published: (2024-11-01)

Tumor microenvironment remodeling after neoadjuvant chemoradiotherapy in local advanced rectal cancer revealed by single-cell RNA sequencing
by: Wenzhao Su, et al.
Published: (2024-11-01)

RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01)

Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma
by: Hongqing Cai, et al.
Published: (2025-01-01)

Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
by: Yutian Lai, et al.
Published: (2025-01-01)

Development and validation of disulfidptosis-related genes signature for patients with glioma
by: Jia Wang, et al.
Published: (2024-12-01)

Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01)

Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma
by: Hongbing Cheng, et al.
Published: (2025-01-01)

Sulforaphane Wrapped in Self-Assembled Nanomicelle Enhances the Effect of Sonodynamic Therapy on Glioma
by: Yihong Li, et al.
Published: (2024-12-01)

Identification of critical biomarkers and immune landscape patterns in glioma based on multi-database
by: Hanzhang Yuan, et al.
Published: (2025-01-01)

The PARPscore system using poly (ADP-ribose) polymerase (PARP) family features and tumor immune microenvironment in glioma
by: Cheng Zhang, et al.
Published: (2024-12-01)

A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma
by: Sanlin Wei, et al.
Published: (2024-12-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade glioma
by: Meik Körner, et al.
Published: (2024-12-01)

Machine learning-based identification of histone deacetylase-associated prognostic factors and prognostic modeling for low-grade glioma
by: Keshan Wen, et al.
Published: (2024-12-01)

CA10 and CA11 negatively regulate neuronal activity‐dependent growth of gliomas
by: Bangbao Tao, et al.
Published: (2019-05-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study
by: Giuseppe Salfi, et al.
Published: (2025-01-01)

Impact of glioma metabolism-related gene ALPK1 on tumor immune heterogeneity and the regulation of the TGF-β pathway
by: YaoFeng Hu, et al.
Published: (2025-01-01)

The dual role of calnexin on malignant progression and tumor microenvironment in glioma
by: Wenxia Wang, et al.
Published: (2024-12-01)

How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?
by: Jeonghee Han
Published: (2023-12-01)

RETRACTED ARTICLE: Construction and validation of a machine learning-based immune-related prognostic model for glioma
by: Qi Mao, et al.
Published: (2024-10-01)

Hemoglobin Level as a Prognostic Factor of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer
by: Berrin Yalçın, et al.
Published: (2024-11-01)

Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer
by: Zhe Chen, et al.
Published: (2025-01-01)

Deciphering the role of heat shock protein HSPA1L: biomarker discovery and prognostic insights in Parkinson's disease and glioma
by: Hong Cheng, et al.
Published: (2024-12-01)

Bibliometric analysis of laryngeal cancer treatment literature (2003–2023)
by: Yan Zhao, et al.
Published: (2025-01-01)

Hormone Receptors in Cervicovaginal Cells
by: Şayeste Demirezen, et al.
Published: (2013-04-01)

Brain gliomas new transcriptomic discoveries from differentially expressed genes to therapeutic targets
by: Shiwen Pei, et al.
Published: (2025-01-01)

A bibliometrics analysis based on the application of artificial intelligence in the field of radiotherapy from 2003 to 2023
by: Minghe Lv, et al.
Published: (2024-11-01)

A Bibliometric and Visualised Analysis of Proliferative Verrucous Leucoplakia From 2003 to 2023
by: Long Zhu, et al.
Published: (2025-02-01)

Combining Endoscopic Submucosal Dissection and Adjuvant Chemoradiotherapy or Radiotherapy for Effective Management of Rectal Cancer with Deep Submucosal Invasion: A Case Series
by: Ji Hye Park, et al.
Published: (2024-11-01)

Effect of chemoradiotherapy on the dynamics of circulating lymphocyte subsets in patients with non-metastatic nasopharyngeal carcinoma
by: Lilan Yi, et al.
Published: (2025-02-01)

Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer
by: Tycho de Bakker, et al.
Published: (2024-12-01)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
by: Qing Liu, et al.
Published: (2024-08-01)

Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome
by: Ravind Pandher, et al.
Published: (2024-12-01)

Meeting Aerobic Physical Activity Guidelines and Associations With Physical Fitness in Men With Metastatic Prostate Cancer: Baseline Results of the Multicentre INTERVAL‐GAP4 Trial
by: Lisa Umlauff, et al.
Published: (2024-12-01)